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Abstract
Understanding the principles of calmodulin (CaM) activation of target enzymes will help delineate
how this seemingly simple molecule can play such a complex role in transducing Ca2+-signals to a
variety of downstream pathways. In the work reported here, we use biochemical and biophysical
tools and a panel of CaM constructs to examine the lobe specific interactions between CaM and
CaMKII necessary for the activation and autophosphorylation of the enzyme. Interestingly, the N-
terminal lobe of CaM by itself was able to partially activate and allow autophosphorylation of
CaMKII while the C-terminal lobe was inactive. When used together, CaMN and CaMC produced
maximal CaMKII activation and autophosphorylation. Moreover, CaMNN and CaMCC (chimeras
of the two N- or C-terminal lobes) both activated the kinase but with greater Kact than for wtCaM.
Isothermal titration calorimetry experiments showed the same rank order of affinities of wtCaM >
CaMNN > CaMCC as those determined in the activity assay and that the CaM to CaMKII subunit
binding ratio was 1:1. Together, our results lead to a proposed sequential mechanism to describe the
activation pathway of CaMKII led by binding of the N-lobe followed by the C-lobe. This mechanism
contrasts the typical sequential binding mode of CaM with other CaM-dependent enzymes, where
the C-lobe of CaM binds first. The consequence of such lobe specific binding mechanisms is
discussed in relation to the differential rates of Ca2+-binding to each lobe of CaM during intracellular
Ca2+ oscillations.
Ca2+/calmodulin-dependent protein kinase II (CaMKII) is found in every tissue in the body
and is the most abundant protein kinase in neurons where it is widely recognized for its
important role in regulating diverse neuronal functions (1). CaMKII is a dodecameric complex
(twelve subunits) (2) and one of its most interesting properties is the ability to phosphorylate
itself (autophosphorylation) following Ca2+/CaM activation, a process that confers Ca2+-
independent activity upon the kinase (3). This autophosphorylation of CaMKII also increases
its affinity for Ca2+/CaM by more than 1,000-fold, commonly referred to as “CaM-
trapping” (4). Thr-286 in the α subunit and Thr-287 in the β, γ and δ subunits has been identified
as the phosphorylation site that lead to these functions changes (1). Substitution of an Ala
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residue at Thr-286 in the α subunit abrogates both Ca2+-independent activity (5) and Ca2+/
CaM-trapping (4).
The interactions between CaMKII and Ca2+/CaM are complex due in part to the association
of subunits into the dodecameric structure. Hanson et al. (6) elegantly documented that
autophosphorylation of Thr-286 occurs through an intersubunit interaction within a
holoenzyme and requires that Ca2+/CaM be bound to neighboring subunits. One subunit serves
as the phosphotransferase reaction and requires the binding of Ca2+/CaM to be active, while
the second adjacent subunit requires binding of Ca2+/CaM to permit Thr-286 to be
phosphorylated. In the case of autophosphorylation, it is clear that two Ca2+/CaMs must bind
simultaneously, and we showed previously that Ca2+/CaM-binding and autophosphorylation
of CaMKII shows cooperativity in all four of the mammalian isoforms (7). In addition, the
initial interaction of Ca2+/CaM with the CaM-binding domain of each subunit imposes
additional kinetic constraints. Using a series of fluorescent derivatives of CaM, Torok et al.
(8) demonstrated that Ca2+/CaM interactions with CaMKII can be divided into at least three
steps. CaM initially binds in an extended conformation via one lobe only. If nucleotide is
present, the second lobe of CaM can interact with CaMKII which leads to a partial collapse of
the two lobes relative to each other and this interaction is apparently sufficient for the bound
subunit to be active. Expression of enzyme activity against an exogenous substrate would not
be expected to exhibit cooperativity for Ca2+/CaM and this was shown to be the case (7). If
two adjacent subunits of CaMKII are bound to Ca2+/CaM, autophosphorylation of Thr-286
ensues and this leads to a third step of very tight binding of Ca2+/CaM that is correlated with
an additional collapse of the two domains of CaM (8). It is this third step that produces the
CaM-trapped form of the kinase. Defining the details of Ca2+-CaM interaction with the kinase
are critical to understand the rate-limiting step that leads to activation and autophosphorylation
of CaMKII in cells.
CaM is a ubiquitous 16.8-kDa (148 amino acid) protein that binds to multiple protein targets,
some in a Ca2+-dependent manner and others in a Ca2+-independent manner (9,10). CaM is
composed of an N- and C-terminal lobe tethered by a flexible linker region that, in total,
resembles a dumbbell when in the non-target bound state. The N- and C-lobes each contain
two EF-hand Ca2+-binding domains separated from each other by the alpha-helical tether
(11) and Ca2+ binding is cooperative within each lobe (12). The C-terminal lobe binds Ca2+
with higher affinity but has slower association and dissociation rates while the N-terminal lobe
has a lower affinity and faster on- and off-rates for Ca2+ (13,14). From these kinetic constants,
one can deduce that during the rising phase of intracellular Ca2+ concentration ([Ca2+]i), the
faster association rates of the N-lobe would dictate that they bind Ca2+. If Ca2+/CaM-binding
targets can interact with the N-terminal lobe of CaM, they would gain a preferential advantage
during the rising phase of a Ca2+-transient over those that bind the C-terminal domain.
Depending on the rate of this association event, the C-terminal lobe may or may not saturate
with Ca2+. As the system relaxes to steady state the C-lobe is more likely to remain Ca2+
saturated because of its higher affinity. This important difference between the Ca2+ binding
affinities in the two lobes imparts on CaM the potential for lobe-specific regulation of its
interactions with target proteins during variations of [Ca2+]i.
It is well documented that target protein interactions significantly impact the Ca2+-binding
properties of CaM. Protein binding can either decrease the binding affinity of CaM for Ca2+
(15,16) or increase the Ca2+-binding affinity (17,18) as anticipated from coupled reactions.
The magnitude of these effects has been documented for several protein enzyme systems,
including Ca2+/CaM interactions with CaMKII (19). We previously identified that the
dissociation rates of Ca2+ from CaM are slowed when bound to CaMKII and that the differences
seemed to correlate with alterations in the release of Ca2+ predominantly from the N-lobe
(16). When bound to the phosphorylated form of CaMKII, Ca2+ dissociation of all four Ca2+
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binding sites is slowed, consistent with the high affinity interaction of CaM bound to phospho-
CaMKII (16).
While we presently lack detailed structural information for Ca2+/CaM bound to native CaMKII,
a synthetic peptide mimicking the CaM-binding domain of the kinase (amino acids 290 to 314)
has been crystallized with Ca2+/CaM (20). A similar peptide containing amino acids 293 to
312 of αCaMKII, was shown to kinetically mimic the association and dissociation kinetics of
the phosphorylated form of CaMKII (21) and we presume the crystal structure best reflects the
contacts made between Ca2+/CaM and autophosphorylated CaMKII. The structure identifies
the typical antiparallel arrangement where the N-terminal domain of the peptide interacts
predominantly, although not exclusively, with amino acids on the C-domain of CaM, and vice
versa (20). This structural data suggests that the two domains of CaM exhibit a preferred
orientation for binding to the CaM-binding domain of CaMKII but how domain specific effects
control enzyme activation and autophosphorylation are not known.
In the present study, we build on earlier kinetic and structural work to investigate domain
specific interactions between CaM and CaMKII. We first analyze the kinetics and steady-state
binding of wtCaM (wild-type CaM) with CaMKII in the presence and absence of ADP to assess
whether preferential binding of the N- or C-domain can be detected. Experiments measuring
Ca2+-dissociation from CaM bound to CaMKII were consistent with the C-domain of CaM
being free, while the N-domain was bound. In the presence of ADP, results obtained were
consistent with the binding of both lobes of CaM to CaMKII. Isothermal titration calorimetry
(ITC) revealed a remarkably weak binding affinity between Ca2+/CaM and CaMKII that
increased significantly in the presence of ADP, consistent with the potential for CaM
interactions via only one lobe in the absence of nucleotide. ITC also showed that Ca2+/CaM
interact with CaMKII subunits at a stoichiometry of close to 1:1 in the presence or absence of
ADP. We then asked whether CaMKII activity and autophosphorylation requires that the two
halves of CaM be physically connected. Genetically engineered half-CaMs, which include
CaM-N(1–75), CaMN(1–80), CaM-C(76–148) (22,23) and CaM-C(81–148) were examined.
CaMN(1–75) with CaMC(76–148) or CaMN(1–80) with CaMC(81–148) were both capable
of supporting activation and autophosphorylation, but CaM-N(1–75) was the only fragment
that, by itself, was sufficient to support the activation and autophosphorylation of CaMKII.
ITC using a high affinity peptide mimetic of the CaM-binding domain of CaMKII revealed
that CaMN(1–75) was the only fragment that bound in a simple manner which suggests that
the inability of the other half-CaMs to activate may be due to inappropriate interactions with
the CaM-binding domain of the kinase. To further assess the domain specificity for activation,
constructs constituting chimeras of the two N- or C-terminal lobes, CaMNN and CaMCC
(24,25), were analyzed. One advantage of using such chimeras is that one maintains the impact
of increasing the effective concentration of the second lobe upon binding of the first, more
typical of wtCaM. Both of these chimeras were shown to activate and induce
autophosphorylation of CaMKII, although CaMNN was ~2-fold more effective than CaMCC.
Using ITC, we identified that wtCaM, CaMNN and CaMCC bound to CaMKII with a one-to-
one stoichiometry and that their rank order of binding was similar to their rank order of CaMKII
activation. Results using stopped-flow fluorimetry and quin-2 induced Ca2+-dissociation,
insured that all of the constructs in this study were still capable of binding Ca2+, although some
unexpected findings were revealed. Together, these results support a sequential model of
CaM’s association to CaMKII with the N-lobe binding first causing an increase in the binding
of nucleotide, leading to the C-lobe interactions and activation of each subunit.
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Experimental Procedures
Protein Expression and Purification
wtCaM was expressed from a codon optimized cDNA in the pET-23d plasmid expressed in E.
coli BL21(DE3)star as previously described (7). The CaMNN and CaMCC clones in pET9
were a gift from Dr. Guy Guillemette (26). CaMN(1–75), CaMN(1–80) and CaMC(76–148)
in T7-7 were gifts from Dr. Madeline Shea (23,27). CaMC81–148 was produced by PCR based
mutagenesis starting with CaMC(76–148) as the template. All cDNAs were expressed in E.
coli BL21(DE3)star (Invitrogen). CaM constructs were purified as described (7) with minor
modifications. The half-CaMs were purified through a modified protocol. Briefly, the pellets
were resuspended in 50 mM Tris, pH 7.5, and 1 mM EDTA, with protease inhibitor cocktail
(Sigma) and sonicated before centrifugation at 18,000 × g for 1 hr at 4°C. The supernatant was
collected and applied to a phenyl-Sepharose CL-4B column (GE Healthcare) previously
equilibrated with 50 mM Tris, pH 7.5 and 2 mM CaCl2. After sample application, the column
was first washed with 50 mM Tris, pH 7.5, 2 mM CaCl2 + 0.5 M NaCl and then with 50 mM
Tris, pH 7.5 and 2 mM CaCl2. CaM was eluted with 50 mM Tris, pH 7.5, and 10 mM EGTA.
Following evaluation with SDS-PAGE, the protein was extensively dialyzed into 50 mM
MOPS, pH 7.0 and stored in this buffer at −20°C. The concentration of each protein was
quantified by a BCA assay kit (Pierce).
For measuring steady-state binding and rates of dissociation, CaM was mutated to Cys at Lys75
and labeled with IAEDANS (Invitrogen) as described (28). CaM(C75) was incubated in 5 mM
DTT for 20 min at room temperature and then desalted over a Biogel P2 column. The reduced
CaM (0.5 mL of 200 µM) was incubated with 10-fold molar excess of IAEDANS in the dark
at room temperature for 4 hr, and then reapplied to the Biogel P2 column. Peak fractions were
pooled and dialyzed overnight against 50 mM MOPS, pH 7.0. The amount of label incorporated
(in M) was calculated by dividing the absorbance at 336 nm (for IAEDANS) by the extinction
coefficient of 5700 M−1cm−1. The concentration of the labeled CaM was determined using a
BCA protein assay (Pierce) with bovine serum albumin as the standard. The dye to protein
ratio in the CaM-C75-DANS preparations used in these experiments was 0.9.
CaMKII expression and purification
A rat αCaMKII cDNA was expressed in the baculovirus system using Sf21 cells as previously
described (28). The kinase was purified from infected cells by phosphocellulose cation
exchange column as described by Bradshaw et al. (29). Briefly, infected cell pellets were
resuspended in lysis buffer (10 mM Tris pH 7.5, 5% betaine, 1 mM EGTA, 1 mM EDTA, 0.5
mM DTT, 0.1 mM PMSF, 5 mg/L leupeptin, and 20 mg/L soybean trypsin inhibitor) and
disrupted by brief sonication. The material was clarified at 4°C at 24,000 rpm in a SW-28 rotor
for 1 hour. The supernatant was applied by gravity flow onto a 2 g phosphocellulose column
(P11 cation exchange resin, Whatman) at 4°C and washed with 50 ml of 50 mM PIPES pH
7.0, 100 mM NaCl. CaMKII was eluted with a linear gradient of 100 mM to 500 mM NaCl.
The peak fractions were dialyzed into 10 mM HEPES, 200 mM KCl, and 20% glycerol at 4°
C. CaMKII was quantified by measuring the absorbance at 280 nm and the concentration (in
M) was calculated using an extinction coefficient of 66975 M−1cm−1. The extinction
coefficient for CaMKII was determined using the ProtParam tool in ExPASy at
http://www.expasy.org/tools/protparam.html (30) and was confirmed using values from a BCA
protein assay.
Autophosphorylation assay
Autophosphorylation of CaMKII was assessed in 20 µl reactions containing 25 mM HEPES,
10 mM MgCl2, 50 mM KCl, 0.4 mM DTT, 100 µM ATP, 4 mM CaCl2 and 2 µCi of 32P-ATP
in the presence of the indicated concentration of CaM. The reaction was carried out on ice for
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10 min, initiated by adding 100 ng of CaMKII and the reactions were terminated by adding
5µl of 4× SDS-sample buffer. 40 ng of kinase were loaded on each lane of a 10% SDS-
polyacrylamide gels. After staining with Coomassie blue and destaining overnight, the
radioactivity incorporated into the enzyme was quantified by exposure of the gel to a phosphor
screen for five hours and detected with a Typhoon scanner (Molecular Dynamics).
Western blot and Immunostaining
Autophosphorylation of CaMKII was also assessed by Western blotting as previously
described (31). A rabbit polyclonal anti-phospho-Thr286-αCaMKII (Anti-ACTIVE CaM
Kinase II pAB, rabbit, pT286, Promega) was used at a 1:5000 dilution. The bound antibody
was visualized by measuring the fluorescence of a secondary antibody (anti-rabbit-IgG labeled
with Alexa 568, dilution 1:5000; Molecular Probes) using the Typhoon scanner.
Activity assay
The activity of CaMKII was assessed in a 25 µl reaction containing 25 mM HEPES, 10 mM
MgCl2, 50 mM KCl, 0.4 mM DTT, 50 µM syntide, 100 µM ATP, 4 mM CaCl2 and 2 µCi
of 32P-ATP. To measure the CaM dependence of CaMKII activity the concentration of the
wtCaM was varied from 1.25 nM to 5 µM, and the concentration of the CaMNN and CaMCC
were varied from 10 nM to 100 µM. The ability of the isolated lobes of CaM to activate the
CaMKII was assessed by varying the concentration of each domain from 25 µM to 500 µM
(final concentrations), either by themselves or in combination of an N-domain and a C-domain.
Reactions were pre-incubated for 1 min at 30°C, initiated by the addition of 10 ng of kinase
and then incubated for 1 minute at 30°C. Reactions were terminated by spotting 20 µl onto
P-81 filters and immersing in 75 mM H3PO4 acid. After air drying, the incorporated
radioactivity was quantified by Cerenkov counting.
Isothermal titration calorimetry
ITC was performed in a Microcal VP-ITC. The buffer for experiments with full length CaMKII
consisted of 25 mM HEPES, pH 7.4, 150 mM KCl, 1 mM MgCl2, 1 mM CaCl2 with or without
1 mM ADP. Purified CaMKII was added to the calorimetry cell at a concentration of 15–20
µM (subunit concentration). Aliquots of 200 µM wtCaM, CaMNN or CaMCC (10 µL) were
automatically injected with constant mixing at 15°C. The data were fit with single or double
site binding models using Microcal software. N reflects the binding stoichiometry, K is the
association constant (K = 1/Kd), ΔH is the enthalpy and ΔS the entropy determined from the
fits. While the fitting function is described as single or double sites, in our experiments, we
use the word mode to encompass the fact that it is possible that ½ CaMs could bind to a single
site in either an N- to C-terminal orientation or a C- to N-terminal orientation. This would
represent two modes of binding to one target site.
For experiments with the CaMKII(291–312) peptide, experiments were performed in a buffer
of 20 mM HEPES pH 7.15, 100 mM NaCl, and 2 mM CaCl2 as previously described (32).
Experiments were performed with a concentration of CaMKII(291–312) of 400 to 600 µM in
the reaction syringe and a concentration of each CaM lobe of 15 to 30 µM in the reaction cell.
The biphasic nature of the titration curves indicated that binding was not always a simple 1:1
ratio. Fitting to the multiple binding site models was performed using the Origin software. The
sequence of the CaMKII(291–312) peptide was: Ac-KKFNARRKLKGAILTTMLATRN-
NH2.
Stopped-flow fluorimetry
All stopped-flow experiments were performed on an Applied Photophysics Ltd. (Leatherhead,
UK) model SV.17 MV sequential stopped flow spectrofluorimeter with a dead time of 1.8 ms.
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For all experiments, data from five to six injections were averaged and then fit with either
single, or double exponential functions. All solutions were made in a buffer containing 20 mM
MOPS pH 7.5, 100 mM KCl and, where applicable, 1 mM MgCl2. The concentrations of
reagents given below are those in the syringes, before mixing. For Ca2+ dissociation using
quin-2, the excitation wavelength was set at 334.5 nm and the detection of fluorescence
emission was controlled by a 435 nm cut-on filter (Oriel #51282). 4 µM CaM and 20 µM
CaCl2 (along with CaM-target and/or nucleotide, as indicated in the figure legends) were mixed
with 150 or 300 µM quin-2 (Molecular Probes, Eugene, OR). In experiments with peptide, 16
µM of Ac-FNARRKLKGAILTTMLATRN-NH2 (CaMKII(293–312)), a high affinity mimetic
of the CaM-binding domain of CaMKII was included (21).
Measurement of CaM affinity
The affinity of CaMKII for CaM-C75-DANS was measured by titrating CaMKII into a solution
of 100 nM (no nucleotide) or 25 nM (with ADP) CaM-C75-DANS in 25 mM MOPS pH.7.0,
150 mM KCl, 0.5 mM CaCl2, 0.1 mg/ml BSA with or without 5 mM MgCl2 and 0.25 mM
ADP. After each addition of CaMKII, fluorescence was measured in a PTI fluorimeter, with
excitation at 345 nm and emission monitored at 465 nm (5 nm bandwidths). For each point,
fluorescence was averaged over a one-minute period. The fraction of CaM bound was
calculated using the equation, , where I is the measured fluorescence
intensity, Ifree is the fluorescence intensity in the absence of CaMKII, and Ibound is the
fluorescence intensity of the fully bound CaM. The x-axis in each graph is the free
concentration of CaMKII at each point, calculated by subtracting the concentration of bound
CaM from the total concentration of CaMKII subunits. Each titration was performed at least
three times, and the data was fit to the Hill equation ( , where h is the Hill coefficient).
RESULTS
The influence of nucleotide on CaM binding to CaMKII
We previously established that the binding of fluorescently labeled CaM-C75-DANS to
CaMKII in the absence of nucleotides exhibited a Hill coefficient of ~2 suggesting
cooperativity in binding (7). Given the site of attachment of the fluorescent moiety, the changes
reported by CaM-C75-DANS are likely dominated by associations of the N-terminal domain
with target proteins. Torok et al. (8) established that under similar reaction conditions, CaM
bound to CaMKII in an extended form, but when nucleotide was added CaM underwent a
conformational rearrangement suggesting both lobes of CaM were now target associated. To
further assess the impact of nucleotide binding on CaM interactions with CaMKII we
completed a series of steady-state and stopped-flow fluorescence studies. Figure 1 shows a
comparison of the steady state fluorescence of CaM-C75-DANS with CaMKII in the presence
and absence of ADP. As reported previously, in the absence of nucleotides, the binding affinity
of CaMKII using this fluorescent reporter for CaM is 62 ± 25 nM and the Hill coefficient was
1.9 ± 0.1. In the presence of a saturating concentration of ADP, the Kd for binding decreased
to 19 ± 4 nM and the Hill coefficient dropped to 1.3 ± 0.3. These values are very similar to
those reported by Torok et al. (8) who reported the Kd determined from kinetic measurements
to be 74 nM and 17 nM in the absence and presence of nucleotide, respectively. Interestingly,
there is also a decrease in cooperativity in CaM-binding to CaMKII in the presence of
nucleotide.
We confirmed that nucleotide binding increases the binding of CaM to CaMKII by analyzing
their interaction with ITC. Figure 2 shows a representative example of such ITC results of
CaM-binding to CaMKII without (panel A) and with (panel B) ADP and the summary data are
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presented in Table 1. The binding affinity measured in the presence of nucleotide was 35 ± 17
nM consistent with the titration curve generated with CaM-C75-DANS. The stoichiometry of
binding (N) was somewhat variable but on average was very close to 1 (0.98 ± 0.2 mol of CaM/
mol of CaMKII subunit). The Kd of Ca2+/CaM binding to CaMKII in the absence of nucleotide
were surprisingly poor with a binding affinity of 1.3 ± 0.6 µM. The stoichiometry of binding
was lower than in the absence of nucleotide, but close to 1 (0.83 ± 0.14 mol of CaM/mol of
CaMKII subunit). It is not immediately apparent why the ITC results indicate a Kd for Ca2+/
CaM binding nearly 20-fold worse than that reported using fluorescence from CaM-C75-
DANS. However, given that IAEDANS is attached to the N-domain near the linker region of
CaM this fluorescent technique may be reporting binding predominantly of the N-lobe. It is
also plausible that the hydrophobic IAEDANS moiety increases the strength of interaction
between CaM and CaMKII consistent with a modest increase in the capacity of CaM-C75-
DANS to activate CaMKII (28). ITC does not depend on an altered form of CaM to report the
binding interaction and is less prone to such potential artifacts. The weak binding reported for
CaM in the absence of nucleotide would be consistent with interactions of CaM predominantly
via one lobe additionally supported by the finding that CaM initially binds to CaMKII in an
extended conformation (8).
We demonstrated previously that when Ca2+/CaM binds to CaMKII in the absence of
nucleotide or when phosphorylated at Thr-286 that there is a dramatic increase in CaM’s
Ca2+-binding affinity (16). These effects can be assessed using the fluorescent Ca2+-chelator
quin-2. As Ca2+ dissociates from CaM it binds to quin-2 producing an increase in fluorescence
and the rates of dissociation can be quantified using stopped-flow fluorescence. Figure 3
demonstrates the relative impact of CaMKII in the absence and presence of ADP on Ca2+-
dissociation from CaM. The Ca2+ dissociation from CaM in the absence of CaMKII shows
only the slow release (9.1 s−1) of 2 mol of Ca2+ from the C-terminal lobe of CaM. The
dissociation of Ca2+ from the N-terminal lobe is too fast to be measured in the absence of target.
In the presence of CaMKII, ~3.3 moles of Ca2+ could be detected that are released at two
different rates. Approximately 2.7 moles of Ca2+ are released at a rate of 9.9 s−1, and ~ 0.6
moles are released at 0.8 s−1. In the presence of ADP, there is a further slowing of Ca2+-
dissociation from CaM. Approximately 1.5 moles of Ca2+ are released at 6.9 s−1, and 2.6 mol
are released at 0.4 s−1 (see Table 2). This data supports the hypothesis that in the presence of
ADP, CaM assumes tighter binding to CaMKII that additionally influences CaM’s affinity for
Ca2+. It is interesting that 2.9 mol of Ca2+ are released from CaM when bound to CaMKII at
a similar rate to the release of Ca2+ from the C-terminal lobe of CaM not in complex with
CaMKII. This result would be consistent with a model where the Ca2+-bound N-terminal
domain binds to CaMKII while the C-terminal lobe interacts little if at all with the enzyme as
previously suggested by Torok et al. (8). These data imply an important asymmetry in the
sequential manner in which the lobes of CaM initially interact with CaMKII, with the Ca2+-
saturated N-lobe appearing to bind first to the kinase.
Role of the isolated N- and C-terminal lobes in the activation and autophosphorylation of
CaMKII
To assess the role of the N- and C-terminal lobes of CaM in their interaction with CaMKII
genetically engineered domains of CaM were utilized. In experiments examining CaMKII
activity towards a synthetic peptide substrate, only the CaMN1–75 fragment was shown to
induce activity of CaMKII (Fig. 4A; Table 3). The response was dose-dependent with a half-
maximal activation of approximately 290 µM; however, even at maximal concentrations
(where activity appeared asymptotic) there was only 35% of maximal activity compared to
wtCaM. Fits of the data to the Hill equation revealed a Hill coefficient of 2.8, indicating that
the activation of CaMKII by the N-terminal domain exhibited significant cooperativity.
Extending the domain to include 5 additional residues to create CaMN1–80 surprisingly
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eliminated the induction of CaMKII activity up to 500 µM. Amino acids 75–80 in CaMN1–
80 were shown previously to interact with helix A of CaM that correlated with lowered Ca2+-
binding affinity and increased thermal stability (33). The underlying reason of how these
interactions would lead to a complete inability to activate CaMKII is presently not clear. All
of our activation assays were accomplished at 4 mM Ca2+ to insure that all of the CaM
fragments would be saturated with Ca2+. The C-terminal domains, CaMC76–148 and
CaMC81–148 were also inactive up to 500 µM. Based on the differences in CaMKII activation
between CaMN1–75 and CaMN1–80, it remains possible that further truncation might produce
an active CaMC lobe by deleting additional residues beyond amino acid 81. We then assessed
whether the isolated domains when mixed together could activate CaMKII. We found that both
CaMN1–75 together with CaMC76–148 and CaMN1–80 with CaMC81–148 were capable of
fully activating CaMKII. Both of these mixtures achieved maximal activation of the enzyme
with the former pair exhibiting slightly lower half-maximal activation than the latter; 122 vs.
197 µM, respectively (Figure 4A and Table 3). Fits to the Hill equation showed that each pair
activated the enzyme cooperatively with comparable Hill coefficients of approximately 2.6.
We next investigated if these domains of CaM could induce autophosphorylation of CaMKII.
These experiments were carried out at the maximum amount of CaM that could be achieved
in this assay which was 500µM. An identical pattern for CaMKII autophosphorylation was
produced as observed for enzyme activation. The N-terminal lobe, CaMN1–75, was the only
lobe that by itself was sufficient to cause the autophosphorylation of CaMKII (Fig. 4B).
Experiments with wtCaM were performed at 4°C, which limits autophosphorylation of
CaMKII to predominantly Thr-286 and avoids other sites within the enzyme (e.g. Thr-305/306
or Thr-253). Using antibodies specific to phosphor-Thr-286, we confirmed that this site was
phosphorylated (Fig. 4B). None of the other domains of CaM alone were able to active the
enzyme. However, as with the substrate activity we found that both CaMN1–75 when mixed
with CaMC76–148 and CaMN1–80 when mixed with CaMC81–148 both induced
autophosphorylation of CaMKII that was confirmed to include Thr-286 with antibody staining
(Fig. 4B). We can confidently conclude from these results that CaMKII activity and its
autophosphorylation do not require that the two domains of CaM are covalently linked. They
also reveal that CaMN1–75 contains unique amino acids that are necessary and sufficient for
enzyme activation and autophosphorylation. It is possible that the C-domain of CaM has a
reduced affinity for binding to CaMKII and that we simply could not achieve adequate
concentrations for activation in our assays. Regardless, the data suggest that either through its
affinity or specific amino acid interactions, the N-domain of CaM plays a critical role in
CaMKII activation.
Titration calorimetry utilizing the N- and C-lobes of CaM
In order to better understand the interaction of the individual lobes of CaM with CaMKII, we
also studied their binding to CaMKII using ITC. Experiments in which the lobes of CaM were
titrated with full length CaMKII provided an insufficient heat signal to deduce conclusions.
Hence, we studied binding of the lobes of CaM to a CaMKII-based peptide. It has previously
been shown that the interaction of CaM with CaMKII-based peptides is a useful model for the
different ways CaM can interact with full length CaMKII (32). For instance, CaM was
previously shown to bind peptides based on the full CaM-binding domain of CaMKII (such as
CaMKII(291–312) used here) with sub-picomolar affinity. Here we observed the interaction
of CaMKII(291–312) with CaMN1–75, CaMN1–80 and CaMC76–148 to be dramatically
weaker than with CaM (see Table 4), corroborating the weaker activation K0.5 values for these
constructs compared to CaM determined above. The interaction of CaMN1–75 with CaMKII
(291–312) at all temperatures studied (5, 15, 25, and 37°C) was well described by a single
binding mode model and provided Kd values in the range of 100 to 1000 nM (Table 4). In
contrast, ITC titrations of both CaMN1–80 and CaMC76–148 were not well described by a
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single binding mode model but were much better described by a two binding mode model (Fig
5). Like the data for CaMN1–75, both these constructs demonstrated their more potent Kd
values in the range of 100 to 1000 nM (Table 4). Together, these experiments indicate 1)
CaMN1–75, CaMN1–80, and CaMC76–148 all interact much more weakly with a CaMKII
(291–312) peptide than full length CaM, 2) CaMN1–75 interacts with CaMKII(291–312) via
a single binding mode but CaMN1–80 and CaMC76–148 are capable of interacting in multiple
ways, and 3) the second mode of binding is weaker for CaMC76–148 compared with CaMN1–
80. These results may explain why CaMN1–75 activates full length CaMKII but CaMN1–80
and CaMC76–148 can not. It is feasible that CaMN1–75 binds full length CaMKII using a
single binding mode that is compatible with CaMKII activation while CaMN1–80 and
CaMC76–148 bind in multiple ways, some of which are nonproductive for CaMKII activation
and hence compete with the binding mode that is required for CaMKII activation.
Chimeras composed of two N- or two C-lobes of CaM in the activation and
autophosphorylation of CaMKII
We found that the isolated C-lobe of CaM was incapable of supporting activation and the
autophosphorylation of CaMKII. One possible reason for this observed inactivation would be
that the isolated domain had a binding affinity too weak to achieve the necessary occupancy
of the CaM-binding sites on CaMKII. We investigated this possibility further using chimeras
composed of two copies of either the C-lobe (CaMCC) or the N-lobe (CaMNN) of CaM which
capitalize on the increased effective concentration of the second lobe following binding of the
first. We first assayed these chimeras for their ability to activate CaMKII. The dose-response
relationships shown in Fig. 6 demonstrate both CaMNN and CaMCC activate CaMKII
(summarized in Table 3). CaMNN had a half-maximal activation of 0.7 µM, CaMCC had a
half-maximal activation of 1.4 µM, and wtCaM had a half-maximal activation of 0.025 µM.
Fits of the data to the Hill equation revealed Hill coefficients of 1.2, 1.4, and 1.1 for CaMNN,
CaMCC, and wtCaM, respectively.
We also examined the capacity of CaMNN and CaMCC to induce autophosphorylation of
CaMKII. Both mutant CaMs (at 100 µM final concentrations) induced autophosphorylation
and at least one of the sites autophosphorylated was confirmed to be Thr-286 (Fig. 6B). In
total, these data demonstrate that the C-terminal lobe, when physically combined with a second
C-terminal lobe is fully capable of activating CaMKII. This implies that the C-domain of CaM
is capable of binding to both of the target sites on a subunit of CaMKII to induce activation.
This conclusion can also be drawn from the CaMNN results. A probable explanation for the
lack of activation of CaMKII by the C-terminal lobe alone (CaMC76–148 or CaMC80–148)
is poor binding affinity or that they bind in a mode that does not lead to activation.
The activation curves showed that the rank order to achieve half-maximal activity was wtCaM,
CaMNN, and CaMCC. These results could be explained either by decreased binding affinities,
or subtleties in the specific interactions between the two domains required for most effective
CaMKII activation. We therefore investigated the binding affinities of these forms of CaM
using ITC. Because of the difficulties in maintaining soluble CaMKII at greater than 20 µM,
we accomplished these experiments in the presence of 1 mM ADP to increase the overall
binding affinity of CaM to CaMKII as described in Fig. 2. Example results are shown in Fig.
7 and the summary data can be found in Table 1. The data revealed that CaMNN and CaMCC,
like wtCaM, bound with close to a 1:1 binding stoichiometry (subunit concentration). The data
also revealed that CaMCC bound to CaMKII with a Kd of 370 ± 7 nM, while CaMNN bound
with complicated properties requiring a two mode model. The tight binding mode had a Kd of
64 ± 4 nM while the weaker mode had a Kd of 340 ± 5 nM. This makes the rank order of binding
affinities of these three forms of CaM, wtCaM>CaMNN>CaMCC, identical to the rank order
of their ability to activate CaMKII.
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Characterization of the Ca2+-binding properties of the CaM constructs
We assumed in interpreting the experiments above that all of the variants of CaM retained their
ability to bind to Ca2+. However, it was possible that construction of truncations or chimeras
of CaM may have disrupted Ca2+-binding. We therefore used stopped-flow fluorimetry to
characterize the Ca2+-dissociation properties of the CaM constructs used in the present study
and the results are summarized in Table 5. Because the Ca2+-binding affinity might have been
poor in the CaM constructs, we monitored quin-2 induced dissociation in the absence and
presence of the high affinity CaM-binding peptide which is known to increase the Ca2+-binding
affinity of CaM (21). For each CaM construct, the amplitude associated with each rate was
normalized by setting the total amplitudes to 100% in the presence of peptide and then
calculating the percent contribution for each component. For example, wtCaM in the presence
of peptide required a two component fit so the total amplitudes of both components were set
to 100% (equivalent to 4 mol total Ca2+). Then the relative contribution of each component
was adjusted to mol of Ca2+ recovered as summarized in Table 5. For wtCaM in the absence
of peptide, only a one component fit was required which showed a rate of dissociation of 10
s−1, typical of that reported for Ca2+-dissociation from the C-terminal lobe of CaM (21). The
amplitude of this single component was approximately equal to that of the C-terminal lobe in
the presence of peptide. Dissociation of Ca2+ from the N-terminal domain of wtCaM is too
fast to measure under the present experimental conditions unless peptide is present. CaMNN
in the presence of peptide showed two components, one with a rate of 6.9 s−1 and the second
with a rate of 0.35 s−1 with normalized amplitudes of 3.7 and 0.3, respectively. Surprisingly,
in the absence of peptide, we could still recover significant amplitude of signal that also showed
two rates; one of 226 s−1 and the other at 8.8 s−1 with normalized amplitudes of 0.7 and 0.5,
respectively. This was unexpected, because Ca2+-dissociation from the N-terminal domain of
wtCaM or from the N-domain alone (see below) is too fast to measure under the present
conditions. This indicates that the Ca2+-binding properties of CaMNN are altered from that
theoretically predicted from the fusion of two N-terminal domains. CaMCC also showed
altered properties. In the presence of peptide, two measured rates of 1.3 and 0.32 s−1 with
amplitudes of 1 and 3, respectively were determined. In the absence of peptide, two rates were
measured - 16.15 and 3.6 s−1 with amplitudes of 3.2 and 0.7, respectively. The theoretically
predicted result for CaMCC, if its binding properties were unperturbed, would have been a rate
of 10 s−1 with an amplitude of 4 mol of Ca2+ released.
We also measured Ca2+-dissociation rates from the half-CaMs using an identical protocol
(Table 5). The C-terminal domain CaMC76–148 showed a single dissociation rate of 13.4
s−1 in the absence of peptide, close to what would be predicted from the C-terminal domain of
wtCaM (10 s−1). Deleting amino acids 76–80 (CaM81–148) produced a significant increase
in the rate of Ca2+-dissociation to 43.3 s−1. Clearly, subtle deletions in the linker region of
CaM can significantly impact the Ca2+-binding properties of the molecule. CaMN1–75 and
CaMN1–80 were not measurably different from each other, but the release of Ca2+ in the
absence of peptide was too fast to measure, so subtle differences as detected above for the
isolated C-terminal domain might also exist, but could not be assessed in the present
experimental set-up. From this data, we conclude that the lack of activation of the CaMN1–
80, CaMC76–184, and CaMC81–148 cannot be ascribed to a lack of Ca2+-binding.
DISCUSSION
Autophosphorylation of CaMKII conveys unique properties on the kinase including Ca2+-
independent activity and CaM-trapping. It is well established that autophosphorylation occurs
through an intersubunit reaction mechanism within each holoenzyme (6,29), and that Ca2+/
CaM binding must occur between neighboring subunits within a holoenzyme (6). It is these
properties that lead to the enzyme’s unique ability to decode the frequency of Ca2+ spikes in
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neurons (34). The rate of autophosphorylation is estimated to be ~20 s−1 at 37°C (29) which
is faster than the estimated rate of Ca2+/CaM dissociation from unphosphorylated CaMKII (1–
2 s−1)(4,8,28). Given that Ca2+/CaM may well be limiting in neurons, Ca2+/CaM-association
and dissociation from CaMKII become the rate limiting steps in autophosphorylation, and
understanding the mechanistic details of CaM interacting with CaMKII is critical.
We have shown that one important factor that determines the affinity of Ca2+-CaM-binding to
CaMKII is nucleotide binding. Our results are very similar to those reported by Torok et al.
(8) who identified that ADP binding to the kinase produces a significant increase in steady-
state binding affinity that is reflected in a decreased rate of Ca2+/CaM dissociation. Previous
work identified that Ca2+/CaM-binding to CaMKII increased the binding affinity of
nucleotides (35). Based on free energy coupling, it is not surprising that the presence of ADP
also increases Ca2+/CaM binding affinity. An important issue is how this increased binding
affinity impacts Ca2+/CaM interactions with unphosphorylated CaMKII in the intracellular
setting. Intracellular nucleotide concentrations are several mM, well beyond what is needed to
occupy the nucleotide binding site of CaMKII. In this circumstance, the relevant binding
affinity for Ca2+/CaM is the 12 nM value, not the 60–120 nM value in the absence of nucleotide.
Tzortzopoulus and Torok (36) reported that the binding affinity of Ca2+/CaM for CaMKII
incapable of phosphorylation of Thr-286 (an Ala-286 mutant) was 4.6 nM in the presence of
ATP, supporting that the binding affinity of CaMKII for Ca2+/CaM inside cells is much lower
than previously considered. This increased binding affinity is largely due to slowed dissociation
of Ca2+/CaM and impacts the lifetime of the Ca2+/CaM-CaMKII complex (4,8,28).
Torok et al. (8) also identified that Ca2+/CaM-binding to unphosphorylated CaMKII left CaM
in an extended conformation, presumably because one of the two domains was unable to make
appropriate contacts with the CaM-binding domain of CaMKII. We discovered that the Ca2+-
dissociation rates of the C-terminal domain of CaM were largely unaffected when bound to
CaMKII, suggesting that CaM is binding to unphosphorylated CaMKII via its N-lobe. In the
presence of ADP, the two domains of CaM collapse indicating that both domains are interacting
with their target binding sites on CaMKII (8). Consistent with this result is our finding that the
Ca2+-dissociation rates from both lobes of CaM are slowed when bound to CaMKII in the
presence of ADP. These results are consistent with a kinetic scheme where the N-terminal lobe
of CaM binds to CaMKII first, followed by nucleotide binding and subsequent exposure of
sites on CaMKII that can productively interact with the C-domain of CaM.
We evaluated the role of the individual domains of CaM in their interaction and activation of
CaMKII with a number of engineered variants. Using this strategy it was possible to produce
quantities of the isolated domains where they could be used at several hundred micromolar
concentrations. These concentrations were required to reveal several interesting findings with
these half-CaMs. We produced two versions of half-CaMs; one pair involved amino acids 1–
75 and 76–148 and the other pair included amino acids 1–80 and 81–148. Both pairs of these
half-CaMs were capable of fully activating CaMKII with half-maximal activation at
concentrations of ~150–200 µM. Both pairs also induced autophosphorylation of CaMKII. We
conclude that there is no requirement for the domains of CaM to be physically tethered to
activate CaMKII or to induce autophosphorylation.
When tested individually, only the N-terminal domain fragment of 1–75 was found to activate
CaMKII. The half-maximal concentration for activation was 290 µM, but even up to 500 µM
CaMN1–75 could not maximally activate the kinase. This domain by itself could also lead to
CaMKII autophosphorylation. Given this observation, it was somewhat surprising that the
CaMN1–80 fragment showed no capacity for activating CaMKII even though when mixed
with CaMC81–148 it was capable of supporting activity. This suggests that in the absence of
the C-terminal lobe, the interaction of CaMN1–80 appears to sterically inhibit the binding of
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a second CaMN1–80 molecule. An alternative possibility is that CaMN1–80 adopts a
conformation different from CaMN1–75 that either alters its ability to bind Ca2+ or alters its
capacity to bind to the target, perhaps forming an autoinhibited conformation. In fact, Faga et
al., reported that amino acids 76–80 in CaMN1–80 fold back and interact with the N-domain
and alter its Ca2+ binding properties and its thermal stability (33). However, since CaN1–80
with CaM81–148 is fully capable of activating CaMKII, it is difficult to envision how these
latter effects could explain the data.
Half-CaMs have been used previously to examine the activation of other CaM-dependent
enzymes. The half-CaMs were most often produced via proteolytic digestion of wtCaM with
subsequent purification of the resulting fragments (37,38). A general conclusion drawn from
these studies is that each CaM-binding enzyme exhibits unique interactions with the isolated
lobes of CaM. For example, myosin light chain kinase (MLCK) from smooth or skeletal muscle
and neuronal nitric oxide synthase (nNOS) also appear to bind through an ordered mechanism,
although in this case the C-terminal domain of CaM binds first followed by the N-terminal
domain (37). However, each of these enzymes also exhibited unique properties when
interacting with the isolated N- and C-domains of CaM. In the case of skeletal muscle MLCK,
the C-terminal domain of CaM alone was capable of producing 65% maximal activation but
only 10% of activation was detected with smooth muscle MLCK. Either lobe independently
was found to activate phosphorylase kinase with the C-terminal lobe being more effective
(39). In contrast, neither lobe was sufficient to induce activity of nNOS (26,37). An important
point to note is that not all of these studies extended the concentration of the half-CaM to the
extent we did in the present study. So, lack of activation could relate to insufficient
concentrations of the half CaMs. Like with MLCK, maximal CaMKII activation appears to
require both lobes of CaM. However, unlike MLCK which appears to bind CaM with an ordered
mechanism of C-terminal lobe followed by the N-terminal lobe, the present results with
CaMKII support the opposite sequence of binding.
A reasonable point of concern with the isolated lobes of CaM is that without the linker domain
they could bind to CaMKII in many possible orientations, some potentially inhibitory, thus
complicating interpretation of the results. We therefore examined chimeras created with two
N- or two C-domains for their ability to activate CaMKII. As anticipated, CaMNN activated
CaMKII and induced autophosphorylation; however, CaMCC also activated CaMKII with a
half maximal activation only twofold higher than CaMNN. These data indicate that both the
N- and C-domains have the necessary contact sites to interact with and activate CaMKII if
provided in the appropriate orientations. The ITC results did reveal that CaMCC had a binding
affinity for CaMKII (in the presence of ADP) poorer than CaMNN which indicates that the N-
domain binding affinity is greater than the C-domain. We can thus interpret the inability of the
isolated C-terminal domain of CaM to activate the kinase as either a poor binding affinity, or
because it binds in an inappropriate orientation on CaMKII, producing an inhibitory effect.
This inhibition can be relieved by the presence of the N-domain either because binding of the
N-domain provides an increase in affinity for binding of the C-lobe or because it forces the C-
domain out of an unproductive/inhibitory interaction with CaMKII. The results with the
chimeric CaMs are distinct from those reported with other CaM-dependent enzymes. CaMNN
was shown not to activate either skeletal or smooth muscle MLCK while CaMCC was active
(24). In contrast, CaMNN was shown to activate neuronal NOS, while CaMCC was inactive
against this target (24,26). CaMKII appears to be the most promiscuous of this subset of CaM-
dependent targets in being activated by both CaMCC and CaMNN.
Through elegant computational strategies, Shifman et al. (40) recently reported the design of
mutants of CaM deficient in Ca2+-binding at the N-terminus (sites 1 and 2) or C-terminus (sites
3 and 4) that were additionally engineered to maintain a closed conformation. They showed
that both of these constructs would bind to and activate CaMKII and interpreted the data to
Forest et al. Page 12
Biochemistry. Author manuscript; available in PMC 2009 October 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
conclude that CaM with only two bound Ca2+ ions can activate the kinase. However, they did
not consider in their interpretation that two CaM molecules might be interacting with the kinase
to produce activation. This can clearly happen since we showed that the isolated N-terminal
domain or isolated N- and C-domains together, were fully capable of activating CaMKII. Thus,
it remains an open question of whether a partially Ca2+-saturated form of native CaM is capable
of activating CaMKII or not.
Our results can also be interpreted from a structural perspective. As noted in the Introduction,
a crystal structure of Ca2+/CaM in association with a high affinity CaM-binding peptide
mimicking the CaM-binding domain of CaMKII is available (20). A model of this structure
(Fig. 8A) shows the typical anti-parallel orientation for Ca2+/CaM-target interactions with the
amino acids of the N-domain of CaM (in blue boxes) interacting with the C-domain of the
target peptide and vice versa. However, a clear sidedness is also evident with most of the N-
domain residues in CaM binding on one side of the helical peptide while those in the C-domain
(in red boxes) bind on the opposite side. Note also that there are amino acids in the target that
react with residues in both the N- and C-lobe of CaM (in yellow boxes). When aligned into the
crystal structure of the inactive catalytic domain of CaMKII (41) one can visualize that the N-
terminal domain of CaM seems to lie in a crevice formed between the autoregulatory domain
and the catalytic domain (Fig. 8B). The C-terminal domain of CaM appears to interact with
the less obstructed face of the CaM-binding domain. This model suggests that the N-domain
may play a role in orienting residues necessary for forming or making the nucleotide binding
pocket accessible. Once nucleotide binds, the remainder of the CaM-binding domain would
interact productively with the C-lobe of CaM leading to enzyme activation. This would be
consistent with our results that the N-domain plays a dominant role in the initial interaction of
CaM with CaMKII that ultimately leads to enzyme activation.
In total, these results indicate that the activation of CaMKII by Ca2+/CaM likely proceeds
through an ordered mechanism. The N-terminal domain binds with higher affinity and appears
to bind first followed by binding of the C-terminal lobe. While the N-terminal domain of CaM
has a poorer affinity for Ca2+ than the C-terminal domain, the N-lobe association rate kinetics
is >50-fold faster (17). During the rising phase of Ca2+-influx, it is the N-terminal domain that
would fill with Ca2+ first and become productive to interact with target proteins. Our data
support that binding of the N-terminal domain is the first step of a sequential mechanism leading
to the productive activation of CaMKII. This means that CaMKII would gain a competitive
advantage over the other CaM-dependent enzymes noted above by utilizing preferential
binding to the N-lobe instead of the C-lobe, since the C-lobe will require a longer period of
time to become fully Ca2+ saturated. Additionally, it appears that nucleotide binding is an
important step between binding of the N-terminal and C-terminal lobes of CaM. This
conclusion is supported by the fact that the dissociation rates of Ca2+ from the C-lobe of CaM
appear unaffected in the presence of CaMKII and that CaM binding to unphosphorylated
CaMKII in the absence of nucleotide is in a fully extended conformation (8). Once both lobes
of Ca2+/CaM are bound the enzyme is capable of supporting phosphorylation of its target
substrates, or if a neighboring subunit is also in the Ca2+/CaM state, autophosphorylation
ensues at Thr-286. Autophosphorylation leads to the exposure of amino acids on CaMKII that
form additional contacts with CaM leading to a further collapse of the two domains of CaM
(8) ultimately producing the high affinity or “CaM-trapped” state of CaMKII.
Abbreviations
CaM, calmodulin
wtCaM, wild-type CaM
CaMN, mutant of CaM composed of only the N lobe
CaMC, mutant of CaM composed on only the C lobe
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CaMN1–75, CaMN composed of amino acids 1–75
CaMN1–80, CaMN composed of amino acids 1–80
CaMC76–148, CaMC composed of amino acids 76–148
CaMC81–148, CaMC composed of amino acids 81–148
CaMNN, a chimeric molecule composed of two N-lobes of CaM
CaMCC, a chimeric molecule composed of two C-lobes of CaM
CaMKII, Ca2+/calmodulin-dependent protein kinase II
MLCK, myosin light chain kinase
nNOS, neuronal nitric oxide synthase
CaM-C75-DANS, IAEDANS-labeled CaM(C75)
IAEDANS, 5-((((2-iodoacetyl)amino)ethyl)amino)napthalene-1-sulfonic acid
ITC, isothermal titration calorimetry
[Ca2+]i, intracellular Ca2+ concentration).
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Figure 1.
Steady-state fluorescence to assess the role of nucleotide binding of CaM to CaMKII. Shown
are the binding curves produced by adding increasing concentrations of CaMKII into a cuvette
containing CaM-C75-DANS (100 nM for no nucleotide and 25 nM with nucleotide) in 25 mM
MOPS, pH 7.0, 150 mM KCl, 0.5 mM CaCl2 containing 0.1 mg/ml bovine serum albumin.
The fraction of CaM bound is plotted against the concentration of free CaMKII. The black dots
are titrations in the absence of ADP and the black squares are in the presence of 5 mM
MgCl2 and 0.25 mM ADP. The fits are to the Hill equation as described in Methodology.
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Figure 2.
Calorimetric data for CaM-binding to CaMKII. The data shown represents the binding of
wtCaM to CaMKII in the absence (A) or presence (B) of 1 mM ADP at 15°C. The top panel
shows the raw power output (µcal/sec) per unit time. The bottom panel shows the integrated
data. The solid line through the data represents the nonlinear least squares best fit of the data
to a 1:1 binding model as described in Materials and Methods. The best fit parameters for these
titration are the following: CaM with no ADP: N = 0.823, Kd = 1.9 µM, ΔH = 1.7 kcal/mol.
CaM with ADP: N = 1.08, Kd = 38 nM, ΔH = −11.1 kcal/mol.
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Figure 3.
Stopped-flow analysis of Ca2+-dissociation from CaM in the presence of CaMKII with or
without ADP. Ca2+ dissociation from CaM was measured by monitoring changes in Quin-2
fluorescence in an Applied Photophysics Ltd. model SV.17MV stopped-flow
spectrofluorimeter at 22°C. 2 µM CaM, 20 µM CaCl2 in 20 mM MOPS pH 7.0, 100 mM KCl,
1 mM MgCl2, without (triangles) or with 2 µM CaMKII (squares) or CaMKII + 1 mM ADP
(circles) was rapidly mixed with 150 µM Quin-2. Quin-2 was excited at 334.5 nm and emission
was monitored through a 435 nm cut-on filter. The representative traces shown are averages
of 5 runs each. The data were converted to mol Ca2+ released/mol CaM by assuming that the
amplitude of Ca2+ release from CaM alone was equal to the release of 2 mol of Ca2+.
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Figure 4.
Substrate phosphorylation and autophosphorylation induced by half-CaMs. A) Each CaM
variant was assessed for its ability to activate CaMKII in reactions containing 25 mM HEPES,
pH 7.4, 50 mM KCl, 0.4 mM DTT, 10 mM MgCl2, 4 mM CaCl2, 100 µM ATP, 50 µM syntide,
and 2 µCi of 32P-ATP. Reactions were initiated by the addition of 10 ng of CaMKII, incubated
for 1 min at 30°C, and terminated by spotting an aliquot on P81 paper and plunging the paper
into phosphoric acid. Each reaction was performed in duplicate and separate experiments were
repeated a minimum of 2 times. The CaM constructs shown are: wtCaM (circles), CaMN1–75
(squares), CaMN1–75 + CaM 76–148 (triangles), CaMN1–80 + CaMC81–148 (upside down
triangles). CaMN1–80, CaMC76–148 and CaMC81–148 were inactive up to the indicated
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concentration (diamond). B) Each CaM variant was assessed for its ability to induce
autophosphorylation of CaMKII. The reaction mixture contained 25 mM HEPES, pH 7.4, 50
mM KCl, 0.4 mM DTT, 10 mM MgCl2, 4 mM CaCl2, 100 µM ATP, and 2 µCi of 32P-ATP.
Reactions were initiated by the addition of 100 ng of CaMKII and were allowed to react for
10 min on ice. The reactions were terminated by the addition of SDS-sample buffer and 40 ng
of CaMKII from each reaction were loaded and run on a 10% SDS-PAGE gel. Following
electrophoresis, staining and destaining, 32P incorporation was assessed by exposing the gel
to a phosphor screen for 5 hr and then analyzing the screen on a Typhoon imaging system.
Identical samples were also analyzed by Western blot with a rabbit polyclonal antibody specific
for phospho-Thr286. The primary antibody was detected with an Alexa568-labeled anti-rabbit
antibody and the signal detected using the fluorescence mode of the Typhoon imaging system.
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Figure 5.
Calorimetric data for binding of lobes of CaM to CaMKII peptide. The data shown represent
binding of (A) CaMN1–75 to CaMKII(291–312) at 25°C and (B) CaMC76–148 to CaMKII
(291–312) at 25°C. The top panel shows the raw power output (µcal/sec) per unit time. The
bottom panel shows the integrated data. The solid line through the data represents the nonlinear
least squares best fit of the data to a 2:1 binding model as described in Materials and Methods.
The best fit parameters for these titration are the following: CaMN1–75: Kd = 360 nM, ΔH =
−2.5 kcal/mol. CaMC76–148: Kd1 = 120 nM, Kd2 = 11900 nM, ΔH1 = −11.8 kcal/mol, ΔH2
= 4.7 kcal/mol.
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Figure 6.
Substrate phosphorylation and autophosphorylation induced by full-length CaM variants. A)
Each CaM variant was assessed for its ability to activate CaMKII exactly as previously
described in figure legend 3. The CaM variants shown are: wtCaM (circles), CaMNN
(triangles), and CaMCC (upside down triangles). B) Each CaM variant was assessed for its
ability to induce autophosphorylation of CaMKII exactly as previously described in figure
legend 3. The top panel shows an autoradiograph of 32P incorporation and the bottom panel is
a blot immuno-stained with a phospho-Thr286 specific monoclonal antibody.
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Figure 7.
Calorimetric data for binding of CaMCC and CaMNN to CaMKII. The data shown represents
the binding of (A) CaMCC or (B) CaMNN to CaMKII in the presence of 1 mM ADP at 15°C.
The top panel shows the raw power output (µcal/sec) per unit time. The bottom panel shows
the integrated data. The solid line through the data represents the nonlinear least squares best
fit of the data to a one site binding model (for CaMCC) or a two site binding model (CaMNN)
as described in Materials and Methods. The best fit parameters for these titration are the
following: CaMCC: N = 0.979, Kd = 360 nM, ΔH = −7.3 kcal/mol. CaMNN: N1 = 0.36, N2 =
0.61, Kd1 = 18 nM, Kd2 = 360 nM, ΔH1 = −6.3 kcal/mol, ΔH2 = −14.7 kcal/mol.
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Figure 8.
Structure and Model of Ca2+/CaM bound to CaMKII. A) Amino acids in CaM are shown in
boxes that interact with residues of the peptide (CKII 293–314) that mimics the CaM-binding
domain of CaMKII. The residues in red are from the C-terminal domain of CaM, blue are from
the N-terminal domain and yellow are from both N- and C-domains. The crystal structure that
this figure is based upon is derived from PDB # 1CM1 (20). B) The complete crystal structure
of PDB #1CM1 was aligned into the crystal structure of the autoinhibited catalytic domain of
CaMKII (PDB# 2BDW) (41). The amino acids of the peptide were superimposed on those
same residues in the CaM-binding domain of the catalytic domain as a means of constraining
the alignment. The backbone of the C-lobe and N-lobes of CaM are shown in red and blue,
respectively. The peptide (CKII 293–314) is in white and the catalytic domain is shown as a
space filling model in grey. The yellow balls represent Ca2+ ions. Note that the N-lobe lies in
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a crevice between the autoregulatory domain and the catalytic domain. This figure was created
using Chimera (http://www.cgl.ucsf.edu/chimera/).
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Table 3
Activation of CaMKII by Mutant CaM Constructs.
CaM mutants Activity
Vmax (µMol/min/mg) K0.5 (µM) Hill coefficient
Wt-CaM 8.25 ± 0.42 0.025 ± 0.003 1.12 ± 0.07
CaM-NN 8.14 ± 1.79 0.71 ± 0.06 1.39 ± 0.08
CaM-CC 7.42 ± 1.38 1.40 ± 0.18 1.21 ± 0.02
CaM-N (1–75) 2.82 ± 0.39 289.87 ± 14.99 2.84 ± 0.28
CaM-N (1–80) no activity
CaM-C (76–148) no activity
CaM-C (81–148) no activity
CaM-N (1–75) + CaM-C (76–148) 7.25 ± 0.66 122.10 ± 10.79 2.56 ± 0.02
CaM-N (1–80) + CaM-C (81–148) 8.13 ± 0.64 197.27 ± 3.90 2.69 ± 0.22
Reactions were performed in duplicate and repeated 2–3 times. Experimental data were fit with the Hill equation (where ‘’a’’ is the Vmax, ‘’b’’ is the
K0.5 and ‘’h’’ is the Hill coefficient). The values reported are means ± standard deviations of the fits from at least two curves.
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Table 5
Quin-2 induced rates of Ca2+ dissociation from CaM constructs
Construct Rate 1 (s−1) Amp. 1 (mol of
Ca2+)
Rate 2 (s−1) Amp. 2 (mol of
Ca2+)
wtCaM TFTM 10 1.8
wtCaM + pep 9.97 1.8 0.19 2.2
CaMNN 226 0.7 8.8 0.5
CaMNN + pep 6.9 3.7 0.35 0.3
CaMCC 16.15 3.2 3.6 0.7
CaMCC + pep 1.3 1.0 0.32 3.0
CaM76–148 13.4 2.1
CaM76–148 + pep 0.56 2
CaM81–148 43.3 1.9
CaM81–148 + pep 1.5 2
CaM1–75 TFTM
CaM1–75 + pep 10.5 2
CaM1–80 TFTM
CaM1–80 + pep 11.4 2
Rates and amplitudes were fit with a one- or two-rate binding model as necessary. Amplitudes reported are the mol of Ca2+ released per mol of protein
assuming 100% of the amplitude was recovered in the presence of peptide. TFTM (too fast to measure) means that fraction of the reaction fell below the
temporal resolution of our instrument (1.8 ms) and could not be reliably detected.
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